HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: thx.2005.049536v1 61/8/684    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kappler, M Articles by Lang, T Search for Related Content PubMed PubMed Citation Articles by Kappler, M Articles by Lang, T

Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis

Children’s University Hospital of the Ludwig-Maximilians-University Munich, Germany

Correspondence to:
Correspondence to:
Professor Dr M Griese
von Haunersches Kinderspital, Ludwig-Maximilians-University, Lindwurmstr 4, 80337 Munich, Germany; Matthias.Griese{at}med.uni-muenchen.de

Background: Eradication of Pseudomonas aeruginosa in patients with cystic fibrosis (CF) is possible if initiated early in the course of colonisation. To detect P aeruginosa as early as possible is therefore a major goal. This study was undertaken to validate a commercialised test for the detection of serum Pseudomonas antibodies in patients with CF.

Methods: A representative cross sectional analysis of serum antibodies against three Pseudomonas antigens (alkaline protease, elastase, and exotoxin A) was performed in 183 patients with CF of mean age 16.7 years and FEV₁ 85.9% predicted. The results were correlated with microbiological results from the previous 2 years to calculate sensitivity, specificity, positive and negative predictive values. The following 2 years were assessed to determine prognostic predictive values.

Results: A combination of all three tested antibodies yielded the best results with a sensitivity of 86%, specificity of 96%, and a positive predictive value of 97%. These values were higher if only patients in whom sputum cultures were available were considered (n = 76, sensitivity 95%, specificity 100%, positive predictive value 100%). The prognostic positive predictive value was high in intermittently infected patients (83%) but low in patients free of infection (33%), whereas the prognostic negative predictive value was high in patients free of infection (78%) and low in intermittently infected patients (58%).

Conclusions: Regular determination of serum antibodies may be useful in CF patients with negative or intermittent but not with positive P aeruginosa status. A rise in antibody titres indicates probable infection and eradication treatment may be initiated even in the absence of microbiological detection of P aeruginosa.

Abbreviations: AP, alkaline protease; CF, cystic fibrosis; E, elastase; EA, exotoxin A; ELISA, enzyme linked immunoassay; FEV₁, forced expiratory volume in 1 second; NPV, negative predictive value; OD, optical density; PPV, positive predictive value

Keywords: cystic fibrosis; Pseudomonas aeruginosa; serum antibodies; serology; prognostic value

This article has been cited by other articles:

				H. G. Upritchard, S. J. Cordwell, and I. L. Lamont Immunoproteomics To Examine Cystic Fibrosis Host Interactions with Extracellular Pseudomonas aeruginosa Proteins Infect. Immun., October 1, 2008; 76(10): 4624 - 4632. [Abstract] [Full Text] [PDF]

				P M Farrell and J R W Govan Pseudomonas serology: confusion, controversy, and challenges Thorax, August 1, 2006; 61(8): 645 - 647. [Full Text] [PDF]